[ | E-mail ] Contact: Aimee Frankmedia@gastro.org 301-941-2620American Gastroenterological Association Bethesda, MD (Aug. 28, 2014) A subset of patients with stage III colon cancer had improved survival rates when treated with irinotecan-based therapy, according to a new study in…
Source:Drug shows promise for subset of stage III colon cancer patients
Thursday, August 28, 2014
Drug shows promise for subset of stage III colon cancer patients
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment